Michael A. Winters

877 total citations
31 papers, 694 citations indexed

About

Michael A. Winters is a scholar working on Epidemiology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Michael A. Winters has authored 31 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Molecular Biology and 9 papers in Biomedical Engineering. Recurrent topics in Michael A. Winters's work include Pneumonia and Respiratory Infections (12 papers), Protein purification and stability (10 papers) and Respiratory viral infections research (8 papers). Michael A. Winters is often cited by papers focused on Pneumonia and Respiratory Infections (12 papers), Protein purification and stability (10 papers) and Respiratory viral infections research (8 papers). Michael A. Winters collaborates with scholars based in United States, France and Israel. Michael A. Winters's co-authors include Pablo G. Debenedetti, Todd M. Przybycien, Steven J. Prestrelski, Barbara L. Knutson, Cynthia L. Stevenson, Ann L. Lee, Barry C. Buckland, Jannette Carey, John E. MacNair and Luwy Musey and has published in prestigious journals such as The Journal of Immunology, Macromolecules and Journal of Chromatography A.

In The Last Decade

Michael A. Winters

28 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Winters United States 12 246 233 180 103 62 31 694
Bonita Durnaś Poland 17 106 0.4× 377 1.6× 80 0.4× 212 2.1× 51 0.8× 45 871
Joaquín Cabrera-Crespo Brazil 15 138 0.6× 250 1.1× 115 0.6× 66 0.6× 22 0.4× 31 550
Shuangshuang Yang China 20 132 0.5× 469 2.0× 373 2.1× 44 0.4× 18 0.3× 42 1.2k
Minna Mäki Finland 15 214 0.9× 258 1.1× 158 0.9× 30 0.3× 22 0.4× 28 742
Germana Lentini Italy 15 109 0.4× 181 0.8× 134 0.7× 45 0.4× 14 0.2× 31 640
Bruno P. Lima United States 14 82 0.3× 499 2.1× 115 0.6× 92 0.9× 67 1.1× 25 983
Elaine L. Ferguson United Kingdom 17 50 0.2× 419 1.8× 188 1.0× 110 1.1× 39 0.6× 31 975
Rikard Slättegård Sweden 9 165 0.7× 381 1.6× 89 0.5× 52 0.5× 41 0.7× 12 876
Narahari S. Pujar United States 13 157 0.6× 648 2.8× 369 2.0× 65 0.6× 13 0.2× 14 1.1k
Akhilesh Kumar Shakya United States 18 83 0.3× 272 1.2× 147 0.8× 24 0.2× 24 0.4× 33 893

Countries citing papers authored by Michael A. Winters

Since Specialization
Citations

This map shows the geographic impact of Michael A. Winters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Winters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Winters more than expected).

Fields of papers citing papers by Michael A. Winters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Winters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Winters. The network helps show where Michael A. Winters may publish in the future.

Co-authorship network of co-authors of Michael A. Winters

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Winters. A scholar is included among the top collaborators of Michael A. Winters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Winters. Michael A. Winters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jia, Xiujuan, et al.. (2025). Characterization of pneumococcal conjugates in vaccine process development by multi-detection hydrodynamic chromatography. Journal of Pharmaceutical and Biomedical Analysis. 261. 116826–116826.
2.
Wang, Yanjie, Nicholas Cunningham, Alyssa Q. Stiving, et al.. (2024). Automated, Quantitative Capillary Western Blots to Analyze Host Cell Proteins in COVID-19 Vaccine Produced in Vero Cell Line. Vaccines. 12(12). 1373–1373.
3.
Lin, Mingxiang, James Z. Deng, Giovanna Scapin, et al.. (2024). Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods. Vaccine. 42(25). 126067–126067. 1 indexed citations
4.
Smith, William J., Rachel Thompson, Yuhua Zhang, et al.. (2023). Impact of aluminum adjuvants on the stability of pneumococcal polysaccharide-protein conjugate vaccines. Vaccine. 41(35). 5113–5125. 4 indexed citations
5.
Thompson, Rachel, et al.. (2023). Purification processes of live virus vaccine candidates expressed in adherent Vero cell lines via multimodal chromatography in flowthrough mode. Biotechnology and Bioengineering. 121(8). 2482–2499. 5 indexed citations
7.
Rustandi, Richard R., et al.. (2023). Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS‐CoV‐2. Biotechnology Journal. 19(1). e2300041–e2300041. 2 indexed citations
9.
Rustandi, Richard R., et al.. (2022). Functional profiling of Covid 19 vaccine candidate by flow virometry. Vaccine. 40(37). 5529–5536. 3 indexed citations
10.
Smith, William J., Patrick L. Ahl, Bei Wang, et al.. (2022). Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines. Vaccine. 40(31). 4182–4189. 4 indexed citations
11.
Kaufhold, Robin M., Michael A. Winters, William J. Smith, et al.. (2021). Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice. Vaccine. 39(30). 4231–4237. 14 indexed citations
12.
Mi, Xue, et al.. (2021). Protein Adsorption on Core-shell Particles: Comparison of Capto™ Core 400 and 700 Resins. Journal of Chromatography A. 1651. 462314–462314. 22 indexed citations
13.
Greenberg, David, Timo Vesikari, David Hurley, et al.. (2018). Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Vaccine. 36(45). 6883–6891. 78 indexed citations
14.
Kaufhold, Robin M., Yuhua Zhang, Denise K. Nawrocki, et al.. (2017). Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain. Vaccine. 35(6). 865–872. 18 indexed citations
15.
Skinner, Julie M., Michael A. Winters, John E. MacNair, et al.. (2010). Preclinical evaluation of a 15-valent pneumococcal polysaccharide-protein conjugate vaccine in infant rhesus monkeys (52.20). The Journal of Immunology. 184(Supplement_1). 52.20–52.20. 2 indexed citations
16.
Murphy, Jason C., et al.. (2005). Monitoring of RNA Clearance in a Novel Plasmid DNA Purification Process. Biotechnology Progress. 21(4). 1213–1219. 5 indexed citations
17.
Winters, Michael A., et al.. (2003). Plasmid DNA Purification by Selective Calcium Silicate Adsorption of Closely Related Impurities. Biotechnology Progress. 19(2). 440–447. 38 indexed citations
18.
Winters, Michael A., et al.. (1999). Protein purification with vapor-phase carbon dioxide. Biotechnology and Bioengineering. 62(3). 247–258. 40 indexed citations
19.
Winters, Michael A., et al.. (1997). Long-Term and High-Temperature Storage of Supercritically-Processed Microparticulate Protein Powders. Pharmaceutical Research. 14(10). 1370–1378. 29 indexed citations
20.
Winters, Michael A., Barbara L. Knutson, Pablo G. Debenedetti, et al.. (1996). Precipitation of Proteins in Supercritical Carbon Dioxide. Journal of Pharmaceutical Sciences. 85(6). 586–594. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026